StockNews.AI
NUTX
StockNews.AI
15 days

NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire is investigating Nutex for possible securities law violations. 2. Nutex stock fell 10.05% after a short report from Blue Orca Capital. 3. Blue Orca alleges Nutex's vendor engaged in fraudulent practices impacting the company. 4. The law firm invites affected investors to discuss potential legal claims. 5. Concerns revolve around Nutex's relationships with problematic third-party vendors.

4m saved
Insight
Article

FAQ

Why Very Bearish?

Nutex's stock price decline indicates significant investor concerns. Similar cases show prolonged downturns following litigation news.

How important is it?

The investigation and accusations are likely to significantly impact investor confidence.

Why Short Term?

Immediate reaction to litigation risk is evident; recovery may take longer, depending on results.

Related Companies

HMDACBTTOO
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Nutex and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) on behalf of Nutex stockholders. Our investigation concerns whether Nutex has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On July 22, 2025, Blue Orca Capital ("Blue Orca") issued a short report on Nutex. The Blue Orca report alleges, among other things, that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for engaging in a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients. Following publication of the Blue Orca report, Nutex's stock price fell $11.18 per share, or 10.05%, to close at $100.01 per share on July 22, 2025. If you purchased or otherwise acquired Nutex shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News